The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release
Abstract
The aim of the present study was to investigate changes in the plasma calcitonin gene-related peptide (CGRP) concentration and platelet serotonin (5-hydroxytriptamine, 5-HT) content during the immediate headache and the delayed genuine migraine attack provoked by nitroglycerin. Fifteen female migraineurs (without aura) and eight controls participated in the study. Sublingual nitroglycerin (0.5 mg) was administered. Blood was collected from the antecubital vein four times: 60 min before and after the nitroglycerin application, and 60 and 120 min after the beginning of the migraine attack (mean 344 and 404 min; 12 subjects). In those subjects who had no migraine attack (11 subjects) a similar time schedule was used. Plasma CGRP concentration increased significantly (P<0.01) during the migraine attack and returned to baseline after the cessation of the migraine. In addition, both change and peak, showed significant positive correlations with migraine headache intensity (P<0.001). However, plasma CGRP concentrations failed to change during immediate headache and in the subjects with no migraine attack. Basal CGRP concentration was significantly higher and platelet 5-HT content tended to be lower in subjects who experienced a migraine attack. Platelet serotonin content decreased significantly (P<0.01) after nitroglycerin in subjects with no migraine attack but no consistent change was observed in patients with migraine attack. In conclusion, the fact that plasma CGRP concentration correlates with the timing and severity of a migraine headache suggests a direct relationship between CGRP and migraine. In contrast, serotonin release from platelets does not provoke migraine, it may even counteract the headache and the concomitant CGRP release in this model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorge, F., Simone, R. D., Marano, E., Nolano, M., Orefice, G., & Carrieri, P. (1988) · Cephalalgia · doi:10.1046/j.1468-2982.1988.0801001.x · Cited by 3,465
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Goadsby, P. J., Edvinsson, L., & Ekman, R. (1990) · Annals of Neurology · doi:10.1002/ana.410280213 · Cited by 1,597
Goadsby, P. J., & Edvinsson, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330109 · Cited by 1,158
Cgrp May Play A Causative Role in Migraine
Lassen, L., Haderslev, P., Jacobsen, V., Iversen, H., Sperling, B., & Olesen, J. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00310.x · Cited by 1,027
Nitric oxide as modulator of neuronal function
Prast, H., & Philippu, A. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00044-7 · Cited by 937
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Doods, H., Hallermayer, G., Wu, D., Entzeroth, M., Rudolf, K., Engel, W., & Eberlein, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703110 · Cited by 466
Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain
Olesen, J., Iversen, H. K., & Thomsen, L. L. (1993) · NeuroReport · doi:10.1097/00001756-199308000-00008 · Cited by 326
Delayed inflammation in rat meninges: implications for migraine pathophysiology
Reuter, U. (2001) · Brain · doi:10.1093/brain/124.12.2490 · Cited by 312
Gallai, V., Sarchielli, P., Floridi, A., Franceschini, M., Codini, M., Glioti, G., Trequattrini, A., & Palumbo, R. (1995) · Cephalalgia · doi:10.1046/j.1468-2982.1995.1505384.x · Cited by 288
Nitric oxide is a key molecule in migraine and other vascular headaches
Olesen, J., Thomsen, L. L., & Iversen, H. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90075-2 · Cited by 280
Fanciullacci, M., Alessandri, M., Figini, M., Geppetti, P., & Michelacci, S. (1995) · Pain · doi:10.1016/0304-3959(94)00097-x · Cited by 279
Serotonin metabolism in migraine
Ferrari, M. D., Odink, J., Tapparelli, C., Van Kempen, G. M. J., Pennings, E. J. M., & Bruyn, G. W. (1989) · Neurology · doi:10.1212/wnl.39.9.1239 · Cited by 269
Sarchielli, P., Alberti, A., Codini, M., Floridi, A., & Gallai, V (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00146.x · Cited by 264
Ashina, M., Bendtsen, L., Jensen, R., Schifter, S., & Olesen, J. (2000) · Pain · doi:10.1016/s0304-3959(00)00232-3 · Cited by 205
Regulation of Calcitonin Gene-Related Peptide Secretion by a Serotonergic Antimigraine Drug
Durham, P. L., & Russo, A. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03423.1999 · Cited by 191
Akerman, S., Williamson, D. J., Kaube, H., & Goadsby, P. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704842 · Cited by 175
Iversen, H. K., & Olesen, J. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1606412.x · Cited by 154
Goadsby, P. J., & Edvinsson, L. I. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1606448.x · Cited by 149
Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis
Párdutz, Á., Krizbai, I. A., Multon, S., Vécsei, L., & Schoenen, J. E. (2000) · Neuroreport · doi:10.1097/00001756-200009280-00008 · Cited by 133
The trigemino-vascular system and migraine.
Buzzi, M. G., & Moskowitz, M. A. (1992) · PubMed · Cited by 91
Párdutz, Á., Multon, S., Malgrange, B., Párducz, Á., Vécsei, L., & Schoenen, J. E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02031.x · Cited by 83
Edvinsson, L. I. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00001 · Cited by 78
How do the Currently Used Prophylactic Agents Work in Migraine?
Goadsby, P. J. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1702085.x · Cited by 69
D’Amico, D., Ferraris, A., Leone, M., Catania, A. P., Carlin, A., Grazzi, L., & Bussone, G. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00304.x · Cited by 67
Garry, M. G., Walton, L. P., & Davis, M. A. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02448-8 · Cited by 60
Goadsby, P. J., & Hoskin, K. L. (1998) · Annals of Neurology · doi:10.1002/ana.410430605 · Cited by 60
Development of CGRP antagonists for the treatment of migraine.
Doods, H. N. (2001) · PubMed · Cited by 44
Experimental Headache in Humans
Iversen, H. K. (1995) · Cephalalgia · doi:10.1046/j.1468-2982.1995.1504281.x · Cited by 38
Christiansen, I. S., Iversen, H. K., & Olesen, J. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00064.x · Cited by 35
Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment
Kántor, S., Gráf, M., Anheuer, Z. E., & Bagdy, G. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00126-7 · Cited by 35
Self-citationIncreased nitric oxide synthase activity in a model of serotonin depletion
Tagliaferro, P. A., Ramos, A. J., López‐Costa, J. J., et al. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00450-0 · Cited by 34
Juhász, G., Zsombók, T., Lászik, A., Jakus, R., Faludi, G., Sótonyi, P., & Bagdy, G. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00834-6 · Cited by 33
Self-citation125I-labeling and purification of peptide hormones and bovine serum albumin
Németh, J., Oroszi, G., Jakab, B., Magyarlak, M. I., Szilvássy, Z., Röth, E., & Farkas, B. (2002) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1015062731674 · Cited by 30
Self-citationDevelopment of a new sensitive CGRP radioimmunoassay for neuropharmacological research.
Németh, J., Görcs, T. J., Helyes, Z., Oroszi, G., Kocsy, T., Pintér, E., & Szolcsányi, J. (1998) · PubMed · Cited by 28
Knyihár‐Csillik, E., Tajti, J., Chadaide, Z., Csillik, B., & Vécsei, L. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1084 · Cited by 22
Systemic nitroglycerin activates peptidergic and catecholaminergic pathways in rat brain
Tassorelli, C., & Joseph, S. A. (1996) · Peptides · doi:10.1016/0196-9781(96)00005-8 · Cited by 15
Cited by
Iyengar, S., Ossipov, M. H., & Johnson, K. W. (2017) · Pain · doi:10.1097/j.pain.0000000000000831 · Cited by 584
Stauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1212 · Cited by 559
The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache
OLESEN, J. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.003 · Cited by 296
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Goadsby, P. J. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.005 · Cited by 279
Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine
Rahmann, A., Wienecke, T., Hansen, J., Fahrenkrug, J., Olesen, J., & Ashina, M. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01497.x · Cited by 257
Metadata
- Authors
- Juhasz, G., Zsombok, T., Modos, E. A., Olajos, S., Jakab, B., Nemeth, J., Szolcsanyi, J., Vitrai, J., & Bagdy, G.
- Venue
- Pain
- Published
- 2003-12
- Volume
- 106
- Issue
- 3
- Pages
- 461-470
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1996875554
- Cited by
- 270
- References
- 36
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.